NURS 6521 Week 9 discussion: Women’s and Men’s Health/Infections and Hematologic Systems, Part I

NURS 6521 Week 9 discussion

Topic: Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders, Part 1 and 2

For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes. NURS 6521 Week 9 discussion.

To Prepare

Review the Resources for this module and reflect on the different health needs and body systems presented.
Your Instructor will assign you a complex case study to focus on for this Discussion. Last name A through M, CASE 1. Last name M through Z, CASE 2.
Consider how you will practice critical decision-making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected. NURS 6521 Week 8 discussion. 

By Day 3 of Week 9

Post a brief description of your patient’s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice of pharmacotherapeutics you would recommend, and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples. NURS 6521 Week 9 discussion. 

Case Study 1

HH is a 68 yo M who has been admitted to the medical ward with community-acquired pneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia, and diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV day (day 3) and azithromycin 500 mg IV day (day 3). Since admission, his clinical status has improved, with decreased oxygen requirements. He is not tolerating a diet at this time with complaints of nausea and vomiting.

Ht: 5’8” Wt: 89 kg

Allergies: Penicillin (rash)

ORDER A PLAGIARISM-FREE PAPER HERE

NURS 6521 Week 9 Discussion Sample Solution

Women’s and Men’s Health/Infections and Hematologic Systems, Part I

Patient Initials:  MD                Age: 68 years                       Gender: Male

Height: 5’8”                     Weight: 89 kg                   Allergies: Penicillin (rash)

Elderly chronic disease cases are the most complicated in coping with other disorders and comorbidity. Nurses who work for this group should be extremely knowledgeable regarding the management of the disease and complex models of practice to deliver evidence-based care successfully. A sixty eight year old guy with HTN, asthma, COPD, and hyperlipidemia has become a case study for this week’s debate. The patient was treated for pneumonia in the neighborhood health facility for three days on average with ceftriaxone 1 g IV and azithromycin of 500 mg IV. The patient has been reported not to tolerate his diet, nausea, and vomiting.

Treatment Regimen

The hallmarking CAP treatment is a 2- to 5 day CAP intervention, accompanied by a period of 7 to 10 days (Files, 2020), Ceftriaxone 1 g IV, and Azithromycin 500 mg IV. Ceftriaxone (Rocephin) is a cephalosporin of the third generation, used often in some penicillin-allergic patients with heart and upper respiratory tract, to avoid infection. The patient also complained of nausea and vomiting and some laboratory investigations were carried out like creatinine levels.

Azithromycin (Zithromax) is a Macrolide given once every day for at least five days in combination therapy and withdrawn for hospitalized patients, often used to exacerbate COPD by acute bacteria (Restrepo, Sibila, & Anzueto, 2018). Pneumonia was identified as the world’s number one cause of contagious mortality in the United States (Restrepo et al., 2018). Although the harmful impact of antibiotics may be synonymous with nausea and vomiting, antiemetic drugs such as pantoprazole 40 mg IV are used regularly to protect the lining of the Bowel from resistance to the oral intake of the individual. For patients to avoid dehydration and hypoglycemia, the patient can be given warm fluids and dextrose.

Patients’ needs

During antibiotic administration, the patient will be tested for medication effectiveness. When the health condition of the individual increases, experimental tests can show that the WBC number has reduced or increased in the usual ranges of respiratory function.

Patient education

Health promotion should be included in the discharge package to tackle more health issues, including diabetes, hyperlipidemia, hypertension, and related nutritional awareness. In order to evaluate drug-to-drug reactions and drug enforcement at home, mediation should be achieved. Resting comfortably and resting properly allows the body the energy to battle the illness. Taking quick breaths and coughing multiple times helps in clearing the mouth and eliminating secretions from the lungs.

            If the patient smokes, he can register support groups, medications, and other forms of stopping smoking, and be advised to stop smoking. Taking over one glass of water a day causes the mucus in the lungs and throat to thin and loosen. Keep a healthy diet to ensure that the body can function properly and heal quickly. Patients suffering from chronic conditions (like liver, heart, or kidney, diabetes or sickle-cell anemia), 65 years or older or have other severe illnesses it is advisable to get a pneumococcal vaccine to protect the individual from future infections of pneumonia (Babcock et al., 2004).

References

Alshami, A., Romero, C., Avila, A., & Varon, J. (2018). Management of hypertensive crises in the elderly. Journal of geriatric cardiology: JGC, 15(7), 504–512. https://doi.org/10.11909/j.issn.1671-5411.2018.07.007

Babcock, H. M., Zack, J. E., Garrison, T., Trovillion, E., Jones, M., Fraser, V. J., & Kollef, M. H. (2004). An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest, 125(6), 2224-2231.

Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s Pharmacotherapeutics for Advanced Practice Providers. St. Louis, MO: Elsevier.